[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:hsv":3},{"name":4,"total":5,"recruiting":5,"trials":6},"HSV",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05266612","Phase I Study VG2025 as a Single Agent and in Combination Therapy With Nivolumab in Subjects With Advanced Malignant Solid Tumors",[11],"Phase 1","RECRUITING","2026-08-26T02:17:22.949982Z","2026-05-05T02:43:29.074063Z"]